Once- Versus Twice-Daily Tacrolimus: Are the Formulations Truly Equivalent?

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.12, 2011-08, pp. : 1561-1577

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Patient Preference Study Comparing Two Extended-Release Morphine Sulfate Formulations (Once-Daily Kadian versus Twice-Daily MS Contin) for Cancer Pain

By Kerr R.O.

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 25-32

Adis International

Access to resources Recommend Favorite

What Is the Best Strategy for Converting from Twice-Daily Divalproex to a Once-Daily Divalproex ER Regimen?: Examinations and Answers via Computer Simulations

By Ronald C. Reed Sandeep Dutta

Clinical Drug Investigation, Vol. 24, Iss. 9, 2004-01 ,pp. : 509-521

Adis International

Access to resources Recommend Favorite

Diabetes mellitus: a `CHD risk equivalent'?

Inpharma, Vol. 1, Iss. 1276, 2001-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Fluticasone propionate: once- vs twice-daily for asthma

Inpharma, Vol. 1, Iss. 1477, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Should the Currently Recommended Twice-Daily Dosing Still be Considered the Most Appropriate Regimen for Treating MRSA Ventilator-Associated Pneumonia with Vancomycin?

By Pea Federico

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 147-152

Adis International

Access to resources Recommend Favorite